Clinical trial
A Multicenter, Single-blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula
NCT03438266 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Single-blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula
- Lead sponsor
- Allergan
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 5, 2018
- Completion date
- August 2, 2018
- Enrollment
- 66 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
age-related volume deficit in the mid-face